X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1675) 1675
hematology (1212) 1212
male (1201) 1201
female (1189) 1189
transplantation (1084) 1084
index medicus (1081) 1081
adult (992) 992
middle aged (939) 939
immunology (747) 747
oncology (691) 691
transplantation conditioning - methods (649) 649
myeloablative agonists - therapeutic use (647) 647
bone-marrow-transplantation (644) 644
adolescent (605) 605
transplantation, homologous (605) 605
treatment outcome (559) 559
stem cells (527) 527
aged (514) 514
hematopoietic stem cells (514) 514
hematopoietic stem cell transplantation (496) 496
child (447) 447
retrospective studies (431) 431
hematology, oncology and palliative medicine (404) 404
chemotherapy (380) 380
versus-host-disease (370) 370
transplantation conditioning (363) 363
stem-cell transplantation (362) 362
hematopoietic stem cell transplantation - methods (361) 361
survival analysis (361) 361
child, preschool (353) 353
myeloablative agonists - administration & dosage (343) 343
vidarabine - analogs & derivatives (294) 294
disease-free survival (293) 293
hematopoietic stem cell transplantation - adverse effects (275) 275
care and treatment (272) 272
cancer (271) 271
health aspects (266) 266
young adult (265) 265
infant (251) 251
graft vs host disease - prevention & control (250) 250
analysis (246) 246
transplantation, autologous (246) 246
recurrence (243) 243
leukemia (241) 241
stem cell transplantation (241) 241
hematologic neoplasms - therapy (239) 239
risk factors (234) 234
bone marrow (233) 233
cyclophosphamide (218) 218
myeloablative therapy (216) 216
myeloablative agonists - adverse effects (211) 211
mortality (210) 210
survival rate (203) 203
therapy (198) 198
follow-up studies (197) 197
transplantation conditioning - adverse effects (196) 196
prognosis (194) 194
graft vs host disease - mortality (192) 192
children (189) 189
unrelated donors (186) 186
total-body irradiation (185) 185
acute myeloid-leukemia (181) 181
busulfan - administration & dosage (181) 181
research (176) 176
graft vs host disease - etiology (167) 167
survival (162) 162
busulfan (161) 161
bone-marrow transplantation (160) 160
fludarabine (159) 159
pediatrics (157) 157
immunosuppressive agents - therapeutic use (154) 154
combined modality therapy (153) 153
antineoplastic combined chemotherapy protocols - therapeutic use (152) 152
article (150) 150
graft vs host disease - immunology (148) 148
remission induction (148) 148
vidarabine - administration & dosage (148) 148
bone marrow transplantation (146) 146
melphalan - administration & dosage (144) 144
patient outcomes (144) 144
prospective studies (143) 143
animals (141) 141
hematologic malignancies (141) 141
vidarabine - therapeutic use (141) 141
leukemia, myeloid, acute - therapy (133) 133
graft survival (131) 131
engraftment (130) 130
time factors (130) 130
cyclophosphamide - administration & dosage (129) 129
multiple myeloma (128) 128
whole-body irradiation (127) 127
multiple myeloma - therapy (126) 126
hematopoietic stem cell transplantation - mortality (125) 125
blood (122) 122
cyclophosphamide - therapeutic use (120) 120
hematologic neoplasms - mortality (119) 119
acute disease (115) 115
melphalan (115) 115
histocompatibility testing (112) 112
risk (112) 112
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1858) 1858
French (13) 13
German (5) 5
Polish (4) 4
Spanish (4) 4
Japanese (3) 3
Korean (3) 3
Russian (3) 3
Chinese (2) 2
Czech (1) 1
Danish (1) 1
Hungarian (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 22, Issue 4, pp. 723 - 730
Abstract After allogeneic hematopoietic stem cell transplantation (HSCT), BK virus–associated hemorrhagic cystitis (BKV-HC) is a common complication. Although... 
Hematology, Oncology and Palliative Medicine | Cidofovir | BK virus | Hemorrhagic cystitis | Hematopoietic stem cell transplantation | BONE-MARROW-TRANSPLANTATION | SINGLE-CENTER | IMMUNOLOGY | LOW-DOSE CIDOFOVIR | RECIPIENTS | NEPHROPATHY | TRANSPLANTATION | REPLICATION | INTERSTITIAL NEPHRITIS | DONOR-TYPE | INTRAVESICULAR CIDOFOVIR | INFECTION | HEMATOLOGY | Hematologic Neoplasms - therapy | Myeloablative Agonists - therapeutic use | Polyomavirus Infections - immunology | Cytosine - analogs & derivatives | Polyomavirus Infections - etiology | BK Virus - drug effects | Hematologic Neoplasms - mortality | Humans | Middle Aged | Hemorrhage - mortality | Cystitis - immunology | Male | Hematologic Neoplasms - pathology | Transplantation, Homologous | Hemorrhage - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Tumor Virus Infections - immunology | Tumor Virus Infections - therapy | Adult | Female | Cytosine - therapeutic use | Retrospective Studies | Cystitis - etiology | Glomerular Filtration Rate | Drug Administration Schedule | Organophosphonates - therapeutic use | Antiviral Agents - therapeutic use | Hemorrhage - therapy | Hemorrhage - immunology | Cystitis - therapy | Graft Survival | Tumor Virus Infections - mortality | Cystitis - mortality | Polyomavirus Infections - mortality | Polyomavirus Infections - therapy | Survival Analysis | Hematologic Neoplasms - immunology | Hematopoietic Stem Cell Transplantation - methods | Transplantation Conditioning | Tumor Virus Infections - etiology | Viral Load - drug effects | BK Virus - physiology | Care and treatment | Transplantation | Cystitis | Hematopoietic stem cells | Stem cells | Medical research | Leptin | Medicine, Experimental | Epstein-Barr virus | Index Medicus | Life Sciences | Cancer
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 01/2018, Volume 65, Issue 1, pp. e26746 - n/a
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 01/2014, Volume 20, Issue 1, pp. 4 - 13
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 09/2017, Volume 23, Issue 9, pp. 1541 - 1548
Although previous studies have demonstrated improved outcomes in umbilical cord blood transplantation (UCBT) by omitting antithymocyte globulin (ATG) in the... 
Acute leukemia | Unrelated peripheral blood stem cell transplantation | Antithymocyte globulin | Umbilical cord blood transplantation | Quality of life | ADULT PATIENTS | RISK-FACTORS | BONE-MARROW-TRANSPLANTATION | IMMUNE RECONSTITUTION | DONORS | IMMUNOLOGY | VERSUS-HOST-DISEASE | CONDITIONING REGIMEN | CHILDREN | TRANSPLANTATION | LYMPHOPROLIFERATIVE DISORDERS | HEMATOLOGY | HEMATOLOGIC MALIGNANCIES | Graft vs Host Disease - therapy | Myeloablative Agonists - therapeutic use | Recurrence | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Leukemia, Myeloid, Acute - immunology | Graft vs Host Disease - immunology | Transplantation, Homologous | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Graft vs Host Disease - mortality | Graft Rejection - mortality | Antilymphocyte Serum - therapeutic use | Adult | Female | Unrelated Donors | Retrospective Studies | Transplantation Conditioning - methods | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Graft Rejection - pathology | Leukemia, Myeloid, Acute - therapy | Siblings | Acute Disease | Leukemia, Myeloid, Acute - pathology | Graft Rejection - prevention & control | Cord Blood Stem Cell Transplantation | Graft vs Host Disease - pathology | Leukemia, Myeloid, Acute - mortality | Adolescent | Survival Analysis | Quality of Life | Graft Rejection - immunology | Chronic Disease | Peripheral Blood Stem Cell Transplantation | Oncology, Experimental | Stem cells | Transplantation | Research | Comparative analysis | Hematopoietic stem cells | Cancer | Care and treatment
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 131, Issue 4, pp. 994 - 1000
Bone marrow transplantation has resulted in life-saving sustained T-cell reconstitution in many infants with severe combined immunodeficiency (SCID), but... 
Allergy and Immunology | hematopoietic stem cell transplantation | immunoglobulin therapy | conditioning regimen | Severe combined immunodeficiency | B-cell function | SURVIVAL | BONE-MARROW-TRANSPLANTATION | SINGLE-CENTER | IMMUNOLOGY | ENGRAFTMENT | TERM IMMUNE RECONSTITUTION | THYMIC OUTPUT | ALLERGY | DISEASE | STEM-CELL | OUTCOMES | Myeloablative Agonists - therapeutic use | Myeloablative Agonists - pharmacology | Graft Survival - immunology | Transplantation Chimera - immunology | Humans | Infant | Receptors, Interleukin-7 - genetics | CD3 Complex - genetics | Bone Marrow Transplantation | B-Lymphocytes - pathology | Severe Combined Immunodeficiency - pathology | Transplantation Conditioning - methods | Receptors, Interleukin-7 - immunology | Infant, Newborn | Busulfan - pharmacology | Immunoglobulins - pharmacology | Busulfan - therapeutic use | Adenosine Deaminase - genetics | Severe Combined Immunodeficiency - therapy | Severe Combined Immunodeficiency - immunology | Severe Combined Immunodeficiency - genetics | B-Lymphocytes - immunology | CD3 Complex - immunology | Immunoglobulins - therapeutic use | Adenosine Deaminase - immunology | Immunoglobulins | Universities and colleges | Gene mutations | T cells | Analysis | Immunodeficiency | Studies | Bone marrow | Chemotherapy | Transplants & implants | Medical screening | Defects | Index Medicus | Abridged Index Medicus
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2017, Volume 141, Issue 3, pp. 621 - 635
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 01/2012, Volume 47, Issue 1, pp. 65 - 72
Journal Article
Journal Article
European Journal of Haematology, ISSN 0902-4441, 03/2018, Volume 100, Issue 3, pp. 241 - 246
Objective Prospective data on the use of granulocyte‐colony‐stimulating factor (G‐CSF) in non‐Hodgkin's lymphoma and its aggressive subtypes, including diffuse... 
socio‐economics and ethics | supportive care | non‐Hodgkin's lymphoma | non-Hodgkin's lymphoma | socio-economics and ethics | ADULT PATIENTS | MULTICENTER | COLONY-STIMULATING FACTOR | EORTC GUIDELINES | SOLID TUMORS | SINGLE-ADMINISTRATION PEGFILGRASTIM | INDUCED FEBRILE NEUTROPENIA | BREAST-CANCER | B-CELL LYMPHOMA | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | Back Pain - chemically induced | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Myeloablative Agonists - adverse effects | Back Pain - physiopathology | Febrile Neutropenia - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Arthralgia - physiopathology | Arthralgia - chemically induced | Febrile Neutropenia - prevention & control | Bone and Bones - drug effects | Back Pain - prevention & control | Patient Safety | Adult | Female | Filgrastim - therapeutic use | Arthralgia - prevention & control | Febrile Neutropenia - physiopathology | Biosimilar Pharmaceuticals - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Hematologic Agents - therapeutic use | Treatment Outcome | Bacterial Infections - prevention & control | Bone and Bones - physiopathology | Myeloablative Agonists - administration & dosage | Aged | Neoplasm Staging | Anti-Bacterial Agents - administration & dosage | Medical research | Chemotherapy | Granulocyte colony-stimulating factor | Analysis | Medicine, Experimental | Lymphomas | Drug therapy | Backache | Business ethics | Neutropenia | Cancer | Pain | Lymphocytes B | Arthralgia | Prophylaxis | Colony-stimulating factor | Non-Hodgkin's lymphoma | Leukocytes (granulocytic) | B-cell lymphoma
Journal Article